Quazepam

CHEMBL1200472 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
386.8 g/mol
LogP
4.0
Phase
4

Quazepam is a long-acting benzodiazepine hypnotic that selectively binds to the omega-1 (BZ1) benzodiazepine receptor subtype, enhancing GABA-A mediated inhibitory neurotransmission to reduce sleep onset latency and increase total sleep time. It is indicated for the short-term treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and early morning awakenings.

น้ำหนักโมเลกุล

386.8000 g/mol

LogP

4.00

TPSA

47.70 Ų

Lipinski RO5

ผ่าน

Pharmacokinetics (PK)

Pharmacodynamics (PD)

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

Fc1ccccc1C1=NCC(=S)N(CC(F)(F)F)c2ccc(Cl)cc21

InChI

InChI=1S/C17H11ClF4N2S/c18-10-5-6-14-12(7-10)16(11-3-1-2-4-13(11)19)23-8-15(25)24(14)9-17(20,21)22/h1-7H,8-9H2

Molecular Formula

C17H11ClF4N2S

HBD / HBA

- / 6

พันธะที่หมุนได้

2

อะตอมหนัก

25

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

Quazepam is a long-acting benzodiazepine hypnotic that selectively binds to the omega-1 (BZ1) benzodiazepine receptor subtype, enhancing GABA-A mediated inhibitory neurotransmission to reduce sleep onset latency and increase total sleep time. It is indicated for the short-term treatment of insomnia characterized by difficulty in falling asleep, frequent nocturnal awakenings, and early morning awakenings.

Yes, Quazepam is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200472. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4999. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.